Swiss public broadcaster rts.ch reports that menopause has developed into a market valued at $20 billion. The figure reflects a growing commercial sector around products and services aimed at women going through the transition.
The report, published on August 9, 2026, points to a broader shift in how menopause is being discussed and addressed commercially. According to rts.ch, the market size marks a significant milestone for an area of women's health that has historically received less attention.
Related coverage cited by the broadcaster adds context. French news outlet Le Point reports that most women say they are not informed about perimenopause, the period leading up to menopause. Meanwhile, franceinfo notes that menopause remains a taboo subject, which has led many women to seek support and information on social media platforms.
The combination of these reports suggests that while the commercial market for menopause products is expanding, gaps in medical guidance and cultural openness persist. The $20 billion valuation, as reported by rts.ch, includes a range of offerings from hormone treatments to wellness products and digital health services.
The trend mirrors a wider pattern in women's health, where consumer demand is rising faster than clinical awareness or public discourse. The reporting from rts.ch, Le Point, and franceinfo indicates that the business opportunity is clear, but the educational and social infrastructure around menopause is still catching up.
What to watch next: whether the growth in the menopause market translates into better-informed patients and more open conversations, or remains primarily a commercial development.
